NCT07186413View on ClinicalTrials.gov

A Study to Compare the Efficacy, Safety and Pharmacokinetics of Trifarotene 50 mcg/g Cream in Chinese Subjects With Acne Vulgaris

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

561

Participants

Timeline

Start Date

September 22, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Acne Vulgaris
Interventions
DRUG

Trifarotene

Trifarotene cream applied QD topically.

DRUG

Vehicle Cream

Vehicle cream applied QD topically.

Sponsors

Lead Sponsor

Galderma R&D
All Listed Sponsors
lead

Galderma R&D

INDUSTRY

NCT07186413 - A Study to Compare the Efficacy, Safety and Pharmacokinetics of Trifarotene 50 mcg/g Cream in Chinese Subjects With Acne Vulgaris | Biotech Hunter | Biotech Hunter